Skip to main content
Login
Contact
Subscribe
Search form
Search
Mammoth Times
Click for weather forecast
Home
Forms
News
Obituaries
Sports/Outdoors
Classifieds
Place an Ad
Photos
Videos
Games
Mountain
Snow Report
Ski Report
Road Conditions
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aimmune Therap
(NQ:
AIMT
)
34.49
USD
UNCHANGED
Last Price
Updated: 7:11 PM EDT, Oct 12, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Aimmune Therap
< Previous
1
2
3
4
5
6
7
Next >
Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
February 25, 2021
Aimmune Therapeutics, a Nestlé Health Science company developing and commercializing treatments for potentially life-threatening food allergies, today announced new clinical data from a pooled analysis...
From
Business Wire News Releases
Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm
November 19, 2020
From
GlobeNewswire News Releases
Health Beverage Market Demand and Growth Analysis 2020 - Prada, Burberry, Chanel, Coach, HERMS
October 30, 2020
Harrisburg, NC -- (SBWIRE) -- 10/30/2020 -- The Health Beverage Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from...
From
SBWire - Latest Press Releases
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
October 15, 2020
Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06733-YGR, on...
From
PR Newswire
Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
October 13, 2020
Société des Produits Nestlé S.A. ("Nestlé") today announced the results of the tender offer by its wholly-owned subsidiary, SPN MergerSub, Inc. ("Purchaser"), to purchase all of the outstanding shares...
From
PR Newswire
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
October 02, 2020
From
InvestorBrandNetwork
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
October 02, 2020
NetworkNewsWire Editorial Coverage
From
PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers
September 23, 2020
From
GlobeNewswire News Releases
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
September 23, 2020
From
GlobeNewswire News Releases
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM
September 20, 2020
From
ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT
September 18, 2020
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Aimmune...
From
PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
September 17, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating:
From
PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc
September 16, 2020
From
GlobeNewswire News Releases
Nestlé commences tender offer for Aimmune Therapeutics, Inc.
September 14, 2020
Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding...
From
PR Newswire
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI
September 12, 2020
From
ACCESSWIRE
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – RST, CBMG, AIMT, AKCA
September 12, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating:
From
Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations
September 11, 2020
From
PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer G
September 10, 2020
From
PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MNTA, BMCH, RST, AIMT
September 05, 2020
From
ACCESSWIRE
Kaskela Law LLC Announces Stockholder Investigation of Aimmune Therapeutics, Inc. (AIMT) and Encourages Investors to Contact the Firm
September 05, 2020
Kaskela Law LLC announces that it is investigating Aimmune Therapeutics, Inc. ("Aimmune") (NASDAQ: AIMT) on behalf of the company's shareholders.
From
PR Newswire
AIMMUNE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aimmune Therapeutics Inc. - AIMT
September 04, 2020
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Aimmune Therapeutics Inc. (NasdaqGS: AIMT)...
From
Business Wire News Releases
Moore Kuehn Encourages MNTA, AIMT, ONDK, and OTEL Investors to Contact Law Firm
September 03, 2020
From
GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - RST, CBMG, AIMT, MR
September 01, 2020
Halper Sadeh LLP, a global investor rights law firm, continues to investigate:
From
PR Newswire
Bullish stock with Highest Volume: $AIMT $PCG $UTSI
September 01, 2020
Tags
The Market Signal
From
The Market Signal
SHAREHOLDER ALERT: WeissLaw LLP Investigates Aimmune Therapeutics, Inc.
August 31, 2020
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aimmune Therapeutics, Inc. ("AIMT" or the "Company") (NASDAQ: AIMT) in...
From
PR Newswire
AIMMUNE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AIMT and Encourages Investors to Contact the Firm
August 31, 2020
From
GlobeNewswire News Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.
August 31, 2020
Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its board of directors concerning the proposed acquisition of the company by Nestlé...
From
Business Wire News Releases
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines?
August 31, 2020
InvestorsObserver issues critical PriceWatch Alerts for AIMT, HUGE, AMRN, TRVN, and AAL.
From
PR Newswire
(AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price?
August 31, 2020
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Aimmune Therapeutics, Inc. ("Aimmune" or the "Company") (NASDAQ: AIMT) breached their...
From
PR Newswire
Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science
August 31, 2020
Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it has entered into...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
X
Username
*
Password
*
Request new password